{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T10:00:17Z","timestamp":1792404017023,"version":"4.4.0"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,2,17]],"date-time":"2023-02-17T00:00:00Z","timestamp":1676592000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100017367","name":"Young Star of Science and Technology in Shaanxi Province","doi-asserted-by":"publisher","award":["2021KJXX-03"],"award-info":[{"award-number":["2021KJXX-03"]}],"id":[{"id":"10.13039\/100017367","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81972811"],"award-info":[{"award-number":["81972811"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018594","name":"Central University Basic Research Fund of China","doi-asserted-by":"publisher","award":["xzy012022094"],"award-info":[{"award-number":["xzy012022094"]}],"id":[{"id":"10.13039\/501100018594","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/j.biopha.2023.114423","type":"journal-article","created":{"date-parts":[[2023,2,21]],"date-time":"2023-02-21T22:02:25Z","timestamp":1677016945000},"page":"114423","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"special_numbering":"C","title":["HIF-1\u03b1 inhibitor YC-1 suppresses triple-negative breast cancer growth and angiogenesis by targeting PlGF\/VEGFR1-induced macrophage polarization"],"prefix":"10.1016","volume":"161","author":[{"given":"Yan","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng-Zhao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu-Jing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Can","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shao-Ying","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liu","family":"Pei-Jun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji-Chang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2023.114423_bib1","article-title":"Association of body mass index and age with subsequent breast cancer risk in premenopausal women","volume":"4","author":"Schoemaker","year":"2018","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.biopha.2023.114423_bib2","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s13046-022-02245-0","article-title":"The SF3B1(R625H) mutation promotes prolactinoma tumor progression through aberrant splicing of DLG1","volume":"41","author":"Guo","year":"2022","journal-title":"J. Exp. Clin. Cancer Res.: CR"},{"key":"10.1016\/j.biopha.2023.114423_bib3","first-page":"571","article-title":"Nucleobase-crosslinked poly(2-oxazoline) nanoparticles as paclitaxel carriers with enhanced stability and ultra-high drug loading capacity for breast cancer therapy","volume":"17","author":"Dong","year":"2022","journal-title":"Asian J. Pharm. Sci."},{"key":"10.1016\/j.biopha.2023.114423_bib4","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.7150\/ijbs.67675","article-title":"Hypoxic pancreatic cancer derived exosomal miR-30b-5p promotes tumor angiogenesis by inhibiting GJA1 expression","volume":"18","author":"Chen","year":"2022","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.biopha.2023.114423_bib5","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1158\/0008-5472.CAN-21-3515","article-title":"Antiangiogenesis: vessel regression, vessel normalization, or both?","volume":"82","author":"Augustin","year":"2022","journal-title":"Cancer Res."},{"key":"10.1016\/j.biopha.2023.114423_bib6","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s40364-021-00312-w","article-title":"Antiangiogenic therapy reverses the immunosuppressive breast cancer microenvironment","volume":"9","author":"Chen","year":"2021","journal-title":"Biomark. Res."},{"key":"10.1016\/j.biopha.2023.114423_bib7","doi-asserted-by":"crossref","first-page":"2666","DOI":"10.1056\/NEJMoa072113","article-title":"Paclitaxel plus bevacizumab versus paclitaxel alone for metastatic breast cancer","volume":"357","author":"Miller","year":"2007","journal-title":"N. Engl. J. Med"},{"key":"10.1016\/j.biopha.2023.114423_bib8","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.ccell.2014.10.006","article-title":"Antiangiogenesis strategies revisited: from starving tumors to alleviating hypoxia","volume":"26","author":"Jain","year":"2014","journal-title":"Cancer Cell"},{"key":"10.1016\/j.biopha.2023.114423_bib9","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.drup.2016.02.002","article-title":"Role of the tumor stroma in resistance to anti-angiogenic therapy","volume":"25","author":"Huijbers","year":"2016","journal-title":"Drug Resist. Update.: Rev. Comment. Antimicrob. Anticancer Chemother."},{"key":"10.1016\/j.biopha.2023.114423_bib10","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.canlet.2013.01.024","article-title":"Tumor-associated macrophages as potential diagnostic and prognostic biomarkers in breast cancer","volume":"332","author":"Tang","year":"2013","journal-title":"Cancer Lett."},{"key":"10.1016\/j.biopha.2023.114423_bib11","first-page":"459","article-title":"Macrophage membrane-mediated targeted drug delivery for treatment of spinal cord injury regardless of the macrophage polarization states","volume":"16","author":"Tang","year":"2021","journal-title":"Asian J. Pharm. Sci."},{"key":"10.1016\/j.biopha.2023.114423_bib12","doi-asserted-by":"crossref","first-page":"3530","DOI":"10.1038\/s41467-021-23164-2","article-title":"Targeting monoamine oxidase A-regulated tumor-associated macrophage polarization for cancer immunotherapy","volume":"12","author":"Wang","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biopha.2023.114423_bib13","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1158\/0008-5472.CAN-18-2545","article-title":"Tumor-associated macrophages enhance tumor hypoxia and aerobic glycolysis","volume":"79","author":"Jeong","year":"2019","journal-title":"Cancer Res."},{"key":"10.1016\/j.biopha.2023.114423_bib14","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.7150\/thno.51777","article-title":"Metabolic regulatory crosstalk between tumor microenvironment and tumor-associated macrophages","volume":"11","author":"Chen","year":"2021","journal-title":"Theranostics"},{"key":"10.1016\/j.biopha.2023.114423_bib15","doi-asserted-by":"crossref","first-page":"2892","DOI":"10.7150\/thno.50928","article-title":"Tumor microenvironment remodeling and tumor therapy based on M2-like tumor associated macrophage-targeting nano-complexes","volume":"11","author":"Han","year":"2021","journal-title":"Theranostics"},{"key":"10.1016\/j.biopha.2023.114423_bib16","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1038\/s41419-020-02926-8","article-title":"M2 macrophage-induced lncRNA PCAT6 facilitates tumorigenesis and angiogenesis of triple-negative breast cancer through modulation of VEGFR2","volume":"11","author":"Dong","year":"2020","journal-title":"Cell death Dis."},{"key":"10.1016\/j.biopha.2023.114423_bib17","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1084\/jem.20181616","article-title":"Metabolically activated adipose tissue macrophages link obesity to triple-negative breast cancer","volume":"216","author":"Tiwari","year":"2019","journal-title":"J. Exp. Med"},{"key":"10.1016\/j.biopha.2023.114423_bib18","doi-asserted-by":"crossref","first-page":"2336","DOI":"10.1172\/JCI46192","article-title":"Adenovirus-mediated HIF-1\u03b1 gene transfer promotes repair of mouse airway allograft microvasculature and attenuates chronic rejection","volume":"121","author":"Jiang","year":"2011","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.biopha.2023.114423_bib19","doi-asserted-by":"crossref","first-page":"2993","DOI":"10.1158\/1078-0432.CCR-15-1839","article-title":"PlGF\/VEGFR-1 signaling promotes macrophage polarization and accelerated tumor progression in obesity","volume":"22","author":"Incio","year":"2016","journal-title":"Clin. Cancer Res.: Off. J. Am. Assoc. Cancer Res."},{"key":"10.1016\/j.biopha.2023.114423_bib20","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.2337\/db15-0519","article-title":"HIF-1 mediates renal fibrosis in OVE26 type 1 diabetic mice","volume":"65","author":"Nayak","year":"2016","journal-title":"Diabetes"},{"key":"10.1016\/j.biopha.2023.114423_bib21","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.cardiores.2005.05.002","article-title":"Constitutively active HIF-1alpha improves perfusion and arterial remodeling in an endovascular model of limb ischemia","volume":"68","author":"Patel","year":"2005","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.biopha.2023.114423_bib22","doi-asserted-by":"crossref","first-page":"218","DOI":"10.2174\/156652411795243414","article-title":"Current Insights into the role of HIF-1 in cutaneous wound healing","volume":"11","author":"Andrikopoulou","year":"2011","journal-title":"Curr. Mol. Med."},{"key":"10.1016\/j.biopha.2023.114423_bib23","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1186\/s13046-019-1211-2","article-title":"Metformin inhibits metastatic breast cancer progression and improves chemosensitivity by inducing vessel normalization via PDGF-B downregulation","volume":"38","author":"Wang","year":"2019","journal-title":"J. Exp. Clin. Cancer Res.: CR"},{"key":"10.1016\/j.biopha.2023.114423_bib24","doi-asserted-by":"crossref","first-page":"44579","DOI":"10.18632\/oncotarget.6373","article-title":"Suppression of tumor angiogenesis by metformin treatment via a mechanism linked to targeting of HER2\/HIF-1alpha\/VEGF secretion axis","volume":"6","author":"Wang","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.biopha.2023.114423_bib25","doi-asserted-by":"crossref","first-page":"73892","DOI":"10.18632\/oncotarget.18029","article-title":"Suppression of hypoxia-induced excessive angiogenesis by metformin via elevating tumor blood perfusion","volume":"8","author":"Wang","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.biopha.2023.114423_bib26","doi-asserted-by":"crossref","first-page":"3825","DOI":"10.1111\/jcmm.13655","article-title":"Metformin's antitumour and anti-angiogenic activities are mediated by skewing macrophage polarization","volume":"22","author":"Ji-Chang","year":"2018","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.biopha.2023.114423_bib27","doi-asserted-by":"crossref","first-page":"4010","DOI":"10.1111\/bph.12708","article-title":"YC-1 inhibits proliferation of breast cancer cells by down-regulating EZH2 expression via activation of c-Cbl and ERK","volume":"171","author":"Chang","year":"2014","journal-title":"Br. J. Pharm."},{"key":"10.1016\/j.biopha.2023.114423_bib28","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1186\/s13046-018-0860-x","article-title":"Anti-inflammatory signaling by mammary tumor cells mediates prometastatic macrophage polarization in an innovative intraductal mouse model for triple-negative breast cancer","volume":"37","author":"Steenbrugge","year":"2018","journal-title":"J. Exp. Clin. Cancer Res.: CR"},{"key":"10.1016\/j.biopha.2023.114423_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2019.101413","article-title":"AR ubiquitination induced by the curcumin analog suppresses growth of temozolomide-resistant glioblastoma through disrupting GPX4-mediated redox homeostasis","volume":"30","author":"Chen","year":"2020","journal-title":"Redox Biol."},{"key":"10.1016\/j.biopha.2023.114423_bib30","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.ccr.2009.01.027","article-title":"Antiangiogenic therapy elicits malignant progression of tumors to increased local invasion and distant metastasis","volume":"15","author":"P\u00e0ez-Ribes","year":"2009","journal-title":"Cancer Cell"},{"key":"10.1016\/j.biopha.2023.114423_bib31","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.ccell.2014.10.015","article-title":"Dual-action combination therapy enhances angiogenesis while reducing tumor growth and spread","volume":"27","author":"Wong","year":"2015","journal-title":"Cancer Cell"},{"key":"10.1016\/j.biopha.2023.114423_bib32","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.ccr.2010.11.009","article-title":"HRG inhibits tumor growth and metastasis by inducing macrophage polarization and vessel normalization through downregulation of PlGF","volume":"19","author":"Rolny","year":"2011","journal-title":"Cancer Cell"},{"key":"10.1016\/j.biopha.2023.114423_bib33","doi-asserted-by":"crossref","DOI":"10.1002\/cac2.12345","article-title":"Tumor-associated macrophages in liver cancer: from mechanisms to therapy","author":"Cheng","year":"2022","journal-title":"Cancer Commun. (Lond., Engl. )"},{"key":"10.1016\/j.biopha.2023.114423_bib34","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1186\/s13046-019-1366-x","article-title":"Tumor vasculature remolding by thalidomide increases delivery and efficacy of cisplatin","volume":"38","author":"Shen","year":"2019","journal-title":"J. Exp. Clin. Cancer Res.: CR"},{"key":"10.1016\/j.biopha.2023.114423_bib35","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1002\/cac2.12272","article-title":"Phosphatidylserine released from apoptotic cells in tumor induces M2-like macrophage polarization through the PSR-STAT3-JMJD3 axis","volume":"42","author":"Liang","year":"2022","journal-title":"Cancer Commun. (Lond., Engl. )"},{"key":"10.1016\/j.biopha.2023.114423_bib36","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1161\/01.RES.0000102937.50486.1B","article-title":"Cell type-specific regulation of angiogenic growth factor gene expression and induction of angiogenesis in nonischemic tissue by a constitutively active form of hypoxia-inducible factor 1","volume":"93","author":"Kelly","year":"2003","journal-title":"Circ. Res."},{"key":"10.1016\/j.biopha.2023.114423_bib37","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s13058-020-01296-5","article-title":"Triple-negative breast cancer molecular subtyping and treatment progress","volume":"22","author":"Yin","year":"2020","journal-title":"Breast Cancer Res.: BCR"},{"key":"10.1016\/j.biopha.2023.114423_bib38","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1158\/2159-8290.CD-18-1177","article-title":"Insights into molecular classifications of triple-negative breast cancer: improving patient selection for treatment","volume":"9","author":"Garrido-Castro","year":"2019","journal-title":"Cancer Discov."},{"key":"10.1016\/j.biopha.2023.114423_bib39","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1056\/NEJMoa1814213","article-title":"Sacituzumab govitecan-hziy in refractory metastatic triple-negative breast cancer","volume":"380","author":"Bardia","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.biopha.2023.114423_bib40","doi-asserted-by":"crossref","first-page":"179","DOI":"10.3892\/ijo.2012.1675","article-title":"The anticancer agent YC-1 suppresses progestin-stimulated VEGF in breast cancer cells and arrests breast tumor development","volume":"42","author":"Carroll","year":"2013","journal-title":"Int J. Oncol."},{"key":"10.1016\/j.biopha.2023.114423_bib41","doi-asserted-by":"crossref","first-page":"248","DOI":"10.5732\/cjc.011.10383","article-title":"YC-1 exerts inhibitory effects on MDA-MB-468 breast cancer cells by targeting EGFR in vitro and in vivo under normoxic condition","volume":"31","author":"Cheng","year":"2012","journal-title":"Chin. J. Cancer"},{"key":"10.1016\/j.biopha.2023.114423_bib42","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.bbcan.2017.10.007","article-title":"Triple negative breast cancer: key role of tumor-associated macrophages in regulating the activity of anti-PD-1\/PD-L1 agents","volume":"1869","author":"Santoni","year":"2018","journal-title":"Biochim. Et. Biophys. Acta Rev. Cancer"},{"key":"10.1016\/j.biopha.2023.114423_bib43","doi-asserted-by":"crossref","first-page":"E2120","DOI":"10.1073\/pnas.1406655111","article-title":"Hypoxia-inducible factor-dependent signaling between triple-negative breast cancer cells and mesenchymal stem cells promotes macrophage recruitment","volume":"111","author":"Chaturvedi","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.biopha.2023.114423_bib44","doi-asserted-by":"crossref","first-page":"E905","DOI":"10.1002\/ijc.27631","article-title":"HIF1A induces expression of the WASF3 metastasis-associated gene under hypoxic conditions","volume":"131","author":"Ghoshal","year":"2012","journal-title":"Int J. Cancer"},{"key":"10.1016\/j.biopha.2023.114423_bib45","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1172\/JCI69244","article-title":"Hypoxia-inducible factor-dependent breast cancer-mesenchymal stem cell bidirectional signaling promotes metastasis","volume":"123","author":"Chaturvedi","year":"2013","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.biopha.2023.114423_bib46","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.semcancer.2008.03.004","article-title":"Macrophage polarization in tumour progression","volume":"18","author":"Sica","year":"2008","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.biopha.2023.114423_bib47","doi-asserted-by":"crossref","first-page":"6347","DOI":"10.1158\/0008-5472.CAN-09-0657","article-title":"Tumor vascular changes mediated by inhibition of oncogenic signaling","volume":"69","author":"Qayum","year":"2009","journal-title":"Cancer Res."},{"key":"10.1016\/j.biopha.2023.114423_bib48","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0006525","article-title":"VEGFR1 activity modulates myeloid cell infiltration in growing lung metastases but is not required for spontaneous metastasis formation","volume":"4","author":"Dawson","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2023.114423_bib49","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.cell.2010.02.039","article-title":"Further pharmacological and genetic evidence for the efficacy of PlGF inhibition in cancer and eye disease","volume":"141","author":"Van de Veire","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.biopha.2023.114423_bib50","doi-asserted-by":"crossref","first-page":"7940","DOI":"10.1021\/acsnano.9b08460","article-title":"Gold nanoparticles induce tumor vessel normalization and impair metastasis by inhibiting endothelial Smad2\/3 signaling","volume":"14","author":"Huang","year":"2020","journal-title":"ACS nano"},{"key":"10.1016\/j.biopha.2023.114423_bib51","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1476-4598-13-7","article-title":"YC-1 enhances the anti-tumor activity of sorafenib through inhibition of signal transducer and activator of transcription 3 (STAT3) in hepatocellular carcinoma","volume":"13","author":"Kong","year":"2014","journal-title":"Mol. Cancer"}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332223002111?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332223002111?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T16:38:50Z","timestamp":1781282330000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332223002111"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":51,"alternative-id":["S0753332223002111"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2023.114423","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"HIF-1\u03b1 inhibitor YC-1 suppresses triple-negative breast cancer growth and angiogenesis by targeting PlGF\/VEGFR1-induced macrophage polarization","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2023.114423","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"114423"}}